Cargando…
The Impact of Granulocyte Colony-Stimulating Factor Administration in a Neutropenic Cancer Patient With COVID-19-Related Acute Respiratory Distress Syndrome
Chemotherapy-induced neutropenia is a serious adverse effect found in cancer patients treated with chemotherapy. As these patients are at risk of infections, granulocyte colony-stimulating factors (G-CSF) are commonly used in these patients to increase neutrophil counts. This report describes a case...
Autores principales: | Mohamed, Ayman, Zavoshi, Shirin, Mahmood, Rabia, Gidda, Harish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040142/ https://www.ncbi.nlm.nih.gov/pubmed/36987465 http://dx.doi.org/10.7759/cureus.35399 |
Ejemplares similares
-
A Case of Left Ventricular Thrombus and Herpetic Esophagitis in an Immunocompetent Patient With COVID-19
por: Mohamed, Ayman, et al.
Publicado: (2023) -
Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor
por: Mokart, Djamel, et al.
Publicado: (2008) -
Managing COVID-19 infection in a Young Acute Myeloid Leukemia Patient Successfully With Antiviral and Granulocyte Colony Stimulating Factor: Playing on a Sticky Wicket
por: Talwar, Dhruv, et al.
Publicado: (2021) -
A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome
por: Robinson, John, et al.
Publicado: (2022) -
Emergency department disposition of non‐neutropenic febrile patients with cancer
por: Bischof, Jason J., et al.
Publicado: (2021)